Literature DB >> 21923968

Determination of the burden of hepatitis C virus infection in Ireland.

L Thornton1, N Murphy, L Jones, J Connell, S Dooley, S Gavin, K Hunter, A Brennan.   

Abstract

Information on the burden of hepatitis C virus (HCV) disease is needed to inform policy decisions on primary and secondary prevention. Specimen-based laboratory data (1989-2004) were converted to person-based data and combined with notification data (2004-2009) to describe the burden of HCV infection in Ireland. More than 10,000 people were confirmed as HCV infected in 1989-2004, with the numbers peaking in 2000. The predominant genotypes were 1 (55%) and 3 (39%). Drug use was the most likely risk factor in 80%, with receipt of blood or blood products in 16%. It is estimated that 20 000-50,000 people in Ireland are chronically infected with HCV, a population prevalence of 0·5-1·2%, which is similar to other countries in Northern Europe. This is the first published estimate of the number of chronic HCV infections in Ireland. These data will be of value in health service planning and will contribute to the understanding of HCV infection in Europe.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21923968     DOI: 10.1017/S0950268811001920

Source DB:  PubMed          Journal:  Epidemiol Infect        ISSN: 0950-2688            Impact factor:   2.451


  16 in total

1.  Opt-out testing for blood-borne viruses in primary care: a multicentre, prospective study.

Authors:  Mark O'Kelly; David Byrne; Edward Naughten; Colm Bergin; Caroline Williams
Journal:  Br J Gen Pract       Date:  2016-04-25       Impact factor: 5.386

2.  Exploring Patient Characteristics and Barriers to Hepatitis C Treatment in Patients on Opioid Substitution Treatment Attending a Community Based Fibro-scanning Clinic.

Authors:  Des Crowley; Walter Cullen; Eamon Laird; John S Lambert; Tina Mc Hugh; Carol Murphy; Marie Claire Van Hout
Journal:  J Transl Int Med       Date:  2017-06-30

Review 3.  HepCare Ireland-a service innovation project.

Authors:  Stephen P Connolly; Gordana Avramovic; Walter Cullen; Tina McHugh; Eileen O'Connor; Geoff Mc Combe; Des Crowley; Anna Marie Naughton; Aidan Horan; John S Lambert
Journal:  Ir J Med Sci       Date:  2020-08-06       Impact factor: 1.568

4.  The impact of hepatitis screening on diagnosis and treatment in rheumatoid arthritis.

Authors:  Richard Conway; Michele F Doran; Finbar D O'Shea; Brendan Crowley; Gaye Cunnane
Journal:  Clin Rheumatol       Date:  2014-04-13       Impact factor: 2.980

5.  Opt-Out Panel Testing for HIV, Hepatitis B and Hepatitis C in an Urban Emergency Department: A Pilot Study.

Authors:  Sarah O'Connell; Darren Lillis; Aoife Cotter; Siobhan O'Dea; Helen Tuite; Catherine Fleming; Brendan Crowley; Ian Fitzgerald; Linda Dalby; Helen Barry; Darragh Shields; Suzanne Norris; Patrick K Plunkett; Colm Bergin
Journal:  PLoS One       Date:  2016-03-11       Impact factor: 3.240

6.  Hepatitis C virus seroprevalence and prevalence of chronic infection in the adult population in Ireland: a study of residual sera, April 2014 to February 2016.

Authors:  Patricia Garvey; Brian O'Grady; Geraldine Franzoni; Maeve Bolger; Katie Irwin Crosby; Jeff Connell; Deirdre Burke; Cillian De Gascun; Lelia Thornton
Journal:  Euro Surveill       Date:  2017-07-27

7.  Effectiveness of triple therapy with direct-acting antivirals for hepatitis C genotype 1 infection: application of propensity score matching in a national HCV treatment registry.

Authors:  Emma Gray; David J Pasta; Suzanne Norris; Aisling O'Leary
Journal:  BMC Health Serv Res       Date:  2017-04-19       Impact factor: 2.655

8.  Hepatitis C in the era of direct-acting antivirals: real-world costs of untreated chronic hepatitis C; a cross-sectional study.

Authors:  Jennifer Ann Kieran; Suzanne Norris; Aisling O'Leary; Cathal Walsh; Raphael Merriman; D Houlihan; P Aiden McCormick; Susan McKiernan; Colm Bergin; Michael Barry
Journal:  BMC Infect Dis       Date:  2015-10-26       Impact factor: 3.090

9.  The status of hepatitis C virus infection among people who inject drugs in the Middle East and North Africa.

Authors:  Sarwat Mahmud; Ghina R Mumtaz; Hiam Chemaitelly; Zaina Al Kanaani; Silva P Kouyoumjian; Joumana G Hermez; Laith J Abu-Raddad
Journal:  Addiction       Date:  2020-02-03       Impact factor: 6.526

10.  Incidence of hepatitis C among people who inject drugs in Ireland.

Authors:  Anne Marie Carew; Niamh Murphy; Jean Long; Kate Hunter; Suzi Lyons; Cathal Walsh; Lelia Thornton
Journal:  Hepatol Med Policy       Date:  2017-01-26
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.